5 Stocks That are Benefiting From Rising Inflation

3. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 83 

Johnson & Johnson (NYSE:JNJ) makes and sells healthcare products. It is one of the favorite health stocks in the finance world. At the end of the fourth quarter of 2021, 83 hedge funds in the database of Insider Monkey held stakes worth $7.3 billion in Johnson & Johnson (NYSE:JNJ), compared to 88 in the previous quarter worth $6.8 billion.

On January 26, Raymond James analyst Jayson Bedford maintained an Outperform rating on Johnson & Johnson (NYSE:JNJ) stock and raised the price target to $185 from $178, noting that the stock seemed safe for 2022 given an attractive valuation and a more active capital deployment program. 

Johnson & Johnson (NYSE:JNJ) is slated for a 60th straight consecutive dividend increase in the first quarter of 2022. Johnson & Johnson (NYSE:JNJ) is also one of the most trusted brands in the healthcare sector with a global reach, shielding the company from market fluctuations in one part of the world, and strong pricing power.